Journal article
Cetuximab-radiotherapy versus cetuximab-radiotherapy plus concurrent chemotherapy in patients with N0-N2a squamous cell carcinoma of the head and neck (SCCHN): Results of the GORTEC 2007-01 phase III randomized trial.
-
Bourhis, Jean
Lausanne University Medical Center, Lausanne, Switzerland;
-
Sun, xu Shan
Besançon Hospital, Besancon, France;
-
Sire, Christian
CH de Bretagne Sud, Lorient, France;
-
Tao, Yungan
Institut Gustave Roussy, Villejuif, France;
-
Martin, Laurent
Centre Guillaume Le Conquerant, Le Havre, France;
-
Khoury, Cedric
Centre Georges-François Leclerc, Dijon, France;
-
Maingon, Philippe
Georges-François Leclerc Center, Radiotherapy Department, Dijon, France;
-
Bardet, Etienne
Centre Rene Gauducheau, Nantes, France;
-
Lapeyre, Michel
Centre Jean Perrin, Clermont, France;
-
Chatellier, Thierry
Clinique Mutualiste, Saint Nazaire, France;
-
Ollivier, Nathalie
Institute Gustave Roussy, Villejuif, France;
-
Cornely, Alexandre
Institute Gustave Roussy, Villejuif, France;
-
Auperin, Anne
Institute Gustave Roussy, Villejuif, France;
Show more…
Published in:
- Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2016, vol. 34, no. 15_suppl, p. 6003-6003
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/46362
Statistics
Document views: 20
File downloads: